Insider Transactions in Q4 2024 at Regis Corp (RGS)
Insider Transaction List (Q4 2024)
Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
---|---|---|---|---|---|
Nov 25
2024
|
Mark Light |
BUY
Grant, award, or other acquisition
|
Direct |
3,200
+28.01%
|
-
|
Nov 25
2024
|
Michael Joseph Mansbach |
BUY
Grant, award, or other acquisition
|
Direct |
3,200
+37.27%
|
-
|
Nov 25
2024
|
Lockie Andrews |
BUY
Grant, award, or other acquisition
|
Direct |
3,200
+37.47%
|
-
|
Nov 25
2024
|
M Ann Rhoades |
BUY
Grant, award, or other acquisition
|
Direct |
3,200
+29.48%
|
-
|
Nov 25
2024
|
Nancy Cunningham Benacci |
BUY
Grant, award, or other acquisition
|
Direct |
3,200
+50.0%
|
-
|
Nov 25
2024
|
Michael J Merriman |
BUY
Grant, award, or other acquisition
|
Direct |
4,800
+30.69%
|
-
|
Nov 22
2024
|
Kersten Delores Zupfer Chief Financial Officer |
BUY
Grant, award, or other acquisition
|
Direct |
5,400
+31.77%
|
-
|
Nov 22
2024
|
John C. Davi EVP, Chief Digital Officer |
BUY
Grant, award, or other acquisition
|
Direct |
5,400
+44.06%
|
-
|
Nov 22
2024
|
James Raymon Suarez EVP Merchandising & Education |
BUY
Grant, award, or other acquisition
|
Direct |
5,400
+38.61%
|
-
|
Nov 22
2024
|
Jim Brian Lain EVP, Brand Operations |
BUY
Grant, award, or other acquisition
|
Direct |
5,400
+37.02%
|
-
|
Nov 22
2024
|
Michelle St. Lawrence De Vore SVP, Marketing |
BUY
Grant, award, or other acquisition
|
Direct |
2,500
+50.0%
|
-
|
Nov 22
2024
|
Michael Heath Ferranti EVP Brand Operations |
BUY
Grant, award, or other acquisition
|
Direct |
5,400
+39.64%
|
-
|
Nov 22
2024
|
Matthew Doctor President and CEO |
BUY
Grant, award, or other acquisition
|
Direct |
16,500
+45.73%
|
-
|
Nov 05
2024
|
James Raymon Suarez EVP Merchandising & Education |
SELL
Payment of exercise price or tax liability
|
Direct |
176
-5.23%
|
$4,048
$23.37 P/Share
|
Nov 05
2024
|
Michael Heath Ferranti EVP Brand Operations |
SELL
Payment of exercise price or tax liability
|
Direct |
93
-3.19%
|
$2,139
$23.37 P/Share
|
Nov 05
2024
|
Kersten Delores Zupfer Chief Financial Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
759
-10.16%
|
$17,457
$23.37 P/Share
|
Nov 05
2024
|
Matthew Doctor President and CEO |
SELL
Payment of exercise price or tax liability
|
Direct |
339
-9.34%
|
$7,797
$23.37 P/Share
|